CINECA IRIS Institutional Research Information System

FERRARO, SARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.126
EU - Europa 849
AS - Asia 334
AF - Africa 138
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
Totale 2.466
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.113
IT - Italia 287
SE - Svezia 253
GB - Regno Unito 100
SG - Singapore 87
IN - India 85
CI - Costa d'Avorio 78
BG - Bulgaria 77
DE - Germania 49
SN - Senegal 35
CN - Cina 32
VN - Vietnam 32
NG - Nigeria 23
FR - Francia 22
HK - Hong Kong 22
JP - Giappone 22
AU - Australia 14
CA - Canada 12
ID - Indonesia 12
IR - Iran 11
ES - Italia 10
FI - Finlandia 9
KR - Corea 9
PL - Polonia 6
PT - Portogallo 6
TR - Turchia 6
RO - Romania 5
IE - Irlanda 4
CZ - Repubblica Ceca 3
GR - Grecia 3
IQ - Iraq 3
UA - Ucraina 3
CH - Svizzera 2
EU - Europa 2
IL - Israele 2
PH - Filippine 2
PK - Pakistan 2
RU - Federazione Russa 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
AT - Austria 1
BR - Brasile 1
CL - Cile 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
KZ - Kazakistan 1
LV - Lettonia 1
MK - Macedonia 1
MX - Messico 1
MY - Malesia 1
NL - Olanda 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SI - Slovenia 1
TH - Thailandia 1
Totale 2.466
Salva come PNG Salva come JPEG
Città #
Chandler 148
Ashburn 113
Fairfield 91
Abidjan 78
Sofia 77
Florence 69
Boardman 61
London 60
New York 57
Princeton 50
Serra 37
Wilmington 36
Dakar 35
Singapore 35
Lawrence 34
Houston 30
Woodbridge 30
Kent 27
Medford 27
Lagos 23
Milan 23
Seattle 22
Cambridge 21
Redwood City 21
Hong Kong 20
Pisa 20
Ann Arbor 17
Hyderabad 17
Mumbai 17
Bremen 15
Rome 15
San Diego 13
Ho Chi Minh City 12
Ogden 12
Jakarta 11
Los Angeles 11
Dong Ket 10
Washington 9
Beijing 8
Marseille 8
Dallas 7
San Francisco 7
Jeju City 6
Naples 6
Turin 6
Baia Mare 5
Dearborn 5
Duncan 5
Lappeenranta 5
New Malden 5
Birmingham 4
Chicago 4
Esslingen am Neckar 4
Madrid 4
Melbourne 4
Mountain View 4
Norwalk 4
Ottawa 4
Pomona 4
Porto Azzurro 4
Redmond 4
Scarlino 4
Tokyo 4
Warsaw 4
Bengaluru 3
Bomba 3
Cepagatti 3
Chennai 3
Denver 3
Edgware 3
Guarda 3
Istanbul 3
Jamshedpur 3
Kariya 3
Lisbon 3
Livorno 3
Mount Horeb 3
Niantic 3
Ōmura 3
Armentières 2
Bielefeld 2
Bologna 2
Brno 2
Carrara 2
Cascina 2
Cebu City 2
Charlotte 2
Dongjak-gu 2
Endicott 2
Fiesole 2
Füllinsdorf 2
Helsinki 2
Kolkata 2
Kunming 2
Linthicum Heights 2
Llanelli 2
Mardi 2
Miami 2
Moscow 2
Mugnano di Napoli 2
Totale 1.620
Salva come PNG Salva come JPEG
Nome #
Potential Direct Costs of Adverse Drug Events and Possible Cost Savings Achievable by their Prevention in Tuscany, Italy: A Model-Based Analysis 108
The Anti-TNF Drugs and the Risk of Lymphoma, Skin Cancer and Melanoma: A Signal Detection Analysis 98
Trajectories of oral budesonide use in Crohn's disease cohort of Tuscan patients (Italy) 90
Validation test for algorithms to identify rheumatoid arthritis patients in the Tuscan healthcare administrative databases 85
The usefulness of listening social media for pharmacovigilance purposes: a systematic review 83
Antibiotic Drugs and Unresolved Sensory Side Effects: Analysis of Eudravigilance Database of Suspected Adverse Drug Reaction Reports 83
Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons 81
Direct health care costs among patients with rheumatoid arthritis before and after the initiation of treatment with JAKi in Tuscany: The LEONARDO study 80
Is There a Risk of Lymphoma Associated With Anti-tumor Necrosis Factor Drugs in Patients With Inflammatory Bowel Disease? A Systematic Review of Observational Studies 79
Longitudinal adherence trajectories to biologic disease modifying anti-rheumatic drugs in Tuscany, Italy 78
Adherence to mesalazine and identification of patients with ulcerative colitis in healthcare administrative databases of Tuscany (Italy) 78
Utilization patterns and healthcare accesses of JAKi used in rheumatoid arthritis patients in Tuscany: The LEONARDO study 70
Listening Social Media for Pharmacovigilance Objectives: Which Usefulness? 70
Anticoagulant Therapy and Risk of Bleeding in Patients with Atrial Fibrillation of Four Italian Regions: The TYRION Study 69
Diagnostic delay, effectiveness and safety outcomes in a real-world cohort of patients with Crohn's disease: Data from administrative databases in Tuscany, Italy 67
Trajectories of use of biologic disease modifying antirheumatic drugs in rheumatoid arthritis: A cohort study of Tuscan patients, Italy 66
Time to biologic treatment and to total colectomy associated with diagnostic delay in ulcerative colitis: Analysis of an Italian regional administrative healthcare database 65
Unresolved gustatory, olfactory and auditory adverse drug reactions to antibiotic drugs: a survey of spontaneous reporting to Eudravigilance 63
Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline 63
Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients 61
Analysis of fatal adverse drug events recorded in several Italian emergency departments (the MEREAFaPS study) 57
Anti-tumor Necrosis Factor Drugs and Risk of Lymphoma in Patients with Inflammatory Bowel Disease 55
Validation of algorithms for selecting rheumatoid arthritis patients in the Tuscan healthcare administrative databases 55
null 54
A Model-Based Analysis on Direct Costs of Adverse Drug Events and Related Cost-Savings Achievable by their Prevention in Tuscany, Italy 54
Trajectories of Adherence to Biologic Disease-Modifying Anti-Rheumatic Drugs in Tuscan Administrative Databases: The Pathfinder Study 54
An overview of the preclinical discovery and development of bamlanivimab for the treatment of novel coronavirus infection (COVID-19): reasons for limited clinical use and lessons for the future 53
Recommendations by the Tuscan Health Authority to Use Infliximab-Biosimilar in the Clinical Practice: Safety Impact 53
Raynaud’s Phenomenon Associated with Calcitonin Gene-Related Peptide (CGRP) Antagonists: a Disproportionality Analysis on VigiBase 52
Anticoagulant Therapy in Patients with Atrial Fibrillation and Risk of Bleeding: Interim Analysis: Tyrion Study 51
The Impact of the COVID-19 “Infodemic” on Drug-Utilization Behaviors: Implications for Pharmacovigilance 51
THE ECONOMIC IMPACT OF THE INTRODUCTION OF INFLIXIMAB-BIOSIMILAR: AN EMPIRICAL ANALYSIS USING THE TUSCANY HEALTHCARE ADMINISTRATIVE DATABASES 51
The Economic Impact of the Introduction of Infliximab-Biosimilar: Preliminary Results from a Study on Rheumatologic Patients in Tuscany, Italy 49
Olfactory and gustatory impairments in COVID-19 patients: Role in early diagnosis and interferences by concomitant drugs 48
Switching from infliximab-originator to infliximab-biosimilar in rheumatologic patients: The clinical impact in Tuscan Region, Italy 46
Risk of hospitalisation associated with benzodiazepines and z-drugs in Italy: a nationwide multicentre study in emergency departments 39
Disproportionality Analysis of ‘‘Early-Onset’’ Tardive Dyskinesia Stratified by Time to Onset Using FAERS Database. 34
Fatal Fat Overload Syndrome Following Intravenous Lipid Emulsion Administration as Antidote in Suspected Anesthetic Intoxication: A Fatal Medication Error. 20
Discontinuation rate to biologic and targeted synthetic DMARDs in rheumatoid arthritis patients: Systematic review and meta-analysis 14
Oral Presentation: Signal of Hypertension Associated with COVID-19 Vaccination: VigiBase (R) Data and Evidence from Real World 13
Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy 11
Lessons learnt from the preclinical discovery and development of ensitrelvir as a COVID-19 therapeutic option 11
Analysis of the Drug Related Emergency Department Admissions in Tuscany: The FARO Project 10
Assessment of Healthcare Facilities Associated with JAKi Drugs Used in Rheumatoid Arthritis Patients in Tuscany, Italy: The LEONARDO 9
Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis 8
Unresolved Gustatory, Olfactory and Auditory Adverse Drug Reactions to Antibiotic Drugs: A Signal Detection Analysis on Publicly Accessible Eudravigilance Data 8
Exploring the relationship between utilization patterns of biologic disease-modifying anti-rheumatic drugs and disease activity in rheumatoid arthritis patients 8
Evaluation of drug-utilization and healthcare facilities use in patients with ulcerative colitis and treated with biologic therapy using data of an Italian healthcare administrative database: Results from michelangelo study 8
Tixagevimab + cilgavimab against SARS-CoV-2: the preclinical and clinical development and real-world evidence 7
Oral Presentation: Accesses to Emergency Department and Hospitalizations in New Users of Biologic Therapies for Ulcerative Colitis in Tuscany: The MICHELANGELO Study 7
Supporting the Spontaneous Reporting by Health Care Professionals of the University Hospital of Pisa, Italy: a Pilot Project from the Unit of Adverse Drug Reactions Monitoring 7
Erratum to: Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System (Drug Safety, (2023), 46, 3, (283-295), 10.1007/s40264-022-01269-x) 6
COVID-19 Vaccines and Thromboembolic Events with Thrombocytopenia: Data from Italian Pharmacovigilance Public Database 5
Potential missed diagnoses of Crohn's disease in tertiary care: impact on drug utilization and healthcare facilities use 5
Preclinical discovery and development of the casirivimab + imdevimab cocktail for the treatment of novel coronavirus infection: the rise and fall 4
Relevant pharmacological interactions between alkylating agents and antiepileptic drugs: Preclinical and clinical data 4
Totale 2.558
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.001
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.001
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020131 0 0 0 12 14 20 20 16 16 8 23 2
2020/2021164 6 3 0 7 9 0 7 3 15 0 16 98
2021/2022621 12 16 70 75 89 88 25 32 31 19 44 120
2022/2023818 110 156 57 45 65 68 27 32 179 1 75 3
2023/2024682 17 34 42 16 65 99 85 48 38 37 104 97
2024/2025125 38 87 0 0 0 0 0 0 0 0 0 0
Totale 2.558